Differential growth patterns among healthy infants fed protein hydrolysate or cow-milk formulas

Julie A Mennella1, Alison K Ventura, Gary K Beauchamp

  • 1Monell Chemical Senses Center, Philadelphia, Pennsylvania, USA. mennella@monell.org

Pediatrics
|December 29, 2010
PubMed

Insights

Infants fed protein hydrolysate formula (PHF) showed normative weight gain, unlike those on cow-milk formula (CMF) with accelerated gain. PHF-fed infants consumed less formula, but acceptance was similar.

Area of Science:

  • Pediatrics
  • Nutrition Science
  • Infant Growth

Background:

  • Infant formulas vary significantly in nutritional composition and sensory characteristics.
  • Understanding the impact of different formula types on infant development is crucial.

Purpose of the Study:

  • To compare feeding behavior and growth in healthy infants consuming extensively protein hydrolysate formula (PHF) versus standard cow-milk formula (CMF).

Main Methods:

  • A randomized study involving infants aged 0.5 to 7.5 months assigned to CMF or PHF.
  • Monthly assessments included infant weight, length, and feeding behavior via videotaping.
  • Growth trajectories and formula acceptance were analyzed using multilevel and mixed-effects models.

Main Results:

  • PHF-fed infants exhibited lower weight-for-length z-scores from 2.5 to 7.5 months compared to CMF-fed infants.
  • Weight gain velocity was slower in the PHF group, with no differences in length-for-age z-scores.
  • PHF-fed infants consumed less formula to satiation, yet maternal ratings of acceptance were comparable between groups.

Conclusions:

  • Cow-milk formula (CMF) feeding was associated with accelerated infant weight gain, while protein hydrolysate formula (PHF) feeding resulted in normative weight gain.
  • The study highlights potential differences in infant growth trajectories based on formula type.
  • Further research is needed to explore the long-term effects of these early growth variations and the underlying metabolic mechanisms.
Abstract

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Oxygen Requirements and Growth Patterns01:29

Oxygen Requirements and Growth Patterns

Microorganisms exhibit diverse oxygen requirements and growth patterns driven by their metabolic strategies and environmental adaptations. Oxygen, while essential for many organisms, can also be toxic under certain conditions, shaping how microorganisms grow and survive.Oxygen Requirements of MicroorganismsMicroorganisms are classified based on their ability to use or tolerate oxygen:● Obligate aerobes like Mycobacterium tuberculosis need oxygen for energy production, as it serves as the...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...